Edwards Lifesciences (EW) Tops Q4 EPS by 3c, Offers Q1 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Northland Capital Remains Positive on Edwards Lifesciences (EW) Long-Term Outlook
February 2, 2017 12:50 PM ESTNorthland Capital Markets analyst Suraj Kalia is sticking with her Outperform rating and $105 price target on Edwards Lifesciences (NYSE: EW) even though the company is hard time meeting lofty Street expectations.
Kalia commented, "Q4-16 revs @ $768M > consensus @ $758M & our estimate @ $763M. GAAP EPS @ $0.73 > our estimate @ $0.71 &... More
Leerink Partners Downgrades Edwards Lifesciences (EW) to Market Perform
February 2, 2017 9:34 AM ESTLeerink Partners downgraded Edwards Lifesciences (NYSE: EW) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $98.02 yesterday.
... More